News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Haven Pharmaceuticals Gets $6 Million, Prepares for Approval


10/30/2012 6:31:21 AM

New Haven Pharmaceuticals Inc. (NHP), which plans to seek approval for a slow-release aspirin product next year, has received a $6.6 million Series A round from a mix of private and public investment groups.

The New Haven, Conn. company received $1.5 million from Connecticut Innovations (CI), a quasi-public authority aimed at helping innovative companies in the state. The remainder of the investment comes from EJ Funds, Kuzari Group, Advantage Capital Partners, Yale University, and individual investors, according to a statement from CI.

Read at Mass High Tech


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES